📝 Star Health and Allied Insurance Company Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Star Health and Allied Insurance Company Limited reported revenue of ₹4,917 crore for the quarter ended June 2026 (Q1 FY27), up 16.2% from ₹4,233 crore in the same quarter last year, and up 5.8% sequentially over the March 2026 quarter.
Net profit rose 109.0% year-on-year to ₹550 crore, from ₹263 crore. Earnings per share (EPS) came in at ₹9.34.
Operating profit stood at ₹425 crore — an operating margin (OPM) of 8.6%, compared with 8.3% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Star Health and Allied Insurance Company Limited posted revenue of ₹17,825 crore, a growth of 10.7% over FY25, with a net profit of ₹557 crore (down 13.8% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹18,509 crore with a net profit of ₹844 crore.
Valuation snapshot
At the current price of ₹548.85, STARHEALTH has a market capitalisation of ₹32,295 crore and a trailing P/E of about 38.3.
Within the Finance & Investments industry, it is the 7th-largest of the 117 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 58.00%, foreign institutional investors (FIIs) 15.85%, domestic institutional investors (DIIs) 18.77%, public shareholders 7.37% of Star Health and Allied Insurance Company Limited.